NCT00481871 · Interventional trial
Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies
Overall registry status Completed
Phase 1 · Phase 2
Conditions B-cell Lymphoma, Hodgkin's Lymphoma, Peripheral T-cell Lymphoma, Relapsed or Refractory Lymphoproliferative Malignancies, Waldenstrom's Macroglobulinemia
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory